Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.

@article{Li2018IdentificationOS,
  title={Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.},
  author={S. Li and Ronghua Yang and X. Sun and Shuncheng Miao and T. Lu and Y. Wang and Y. Wo and W. Jiao},
  journal={Gene},
  year={2018},
  volume={679},
  pages={
          398-404
        }
}
We identified and investigated the prognostic value of secreted phosphoprotein 1 (SPP1) in lung adenocarcinoma (LUAD) patients and evaluate the relationship between the SPP1 expression level and clinical characteristics. First, SPP1 was identified through four LUAD datasets in GEO database and validated by the TCGA database. Then a total of 149 lung adenocarcinoma patients were included, as well as their clinicopathological characteristics collected in the study. The expression levels of SPP1… Expand
16 Citations
Differences in key genes in human alveolar macrophages between phenotypically normal smokers and nonsmokers: diagnostic and prognostic value in lung cancer.
  • Yi-De Wang, Z. Li, F. Li
  • Medicine, Biology
  • International journal of clinical and experimental pathology
  • 2020
  • PDF
...
1
2
...

References

SHOWING 1-10 OF 16 REFERENCES
KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma
  • E. Nadal, G. Chen, +12 authors N. Ramnath
  • Medicine
  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2014
  • 44
Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
  • 58
X-Tile
  • 1,218
  • PDF
...
1
2
...